“In My Experience…15 Data Points To Better Evaluate Platelet Rich Plasma Kits And Protocols”

Don Buford, Nathan Sherman
{"title":"“In My Experience…15 Data Points To Better Evaluate Platelet Rich Plasma Kits And Protocols”","authors":"Don Buford, Nathan Sherman","doi":"10.60118/001c.118697","DOIUrl":null,"url":null,"abstract":"Platelet rich plasma (PRP) use in orthopedics is growing. Clinical research documenting effective outcomes for various conditions is fueling interest in PRP as a safe intervention for many soft tissue and joint pathologies in orthopedics. However, clinicians do not have a consistent means to evaluate PRP as a biologic drug and as a result interpreting clinical reports can be challenging. Additionally, clinicians often do not have the necessary information to fully evaluate PRP kits and protocols when deciding on how to best integrate this therapy into their practice. This paper defines 15 different metrics that can be used to quantify PRP and to compare PRP kits and protocols. Our goal is to provide a comprehensive framework that allows for the unbiased evaluation of PRP regardless of the kit or protocol used. By using these PRP metrics routinely, we can improve characterization PRP for research and clinical purposes.","PeriodicalId":298624,"journal":{"name":"Journal of Orthopaedic Experience & Innovation","volume":"56 32","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Orthopaedic Experience & Innovation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.60118/001c.118697","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Platelet rich plasma (PRP) use in orthopedics is growing. Clinical research documenting effective outcomes for various conditions is fueling interest in PRP as a safe intervention for many soft tissue and joint pathologies in orthopedics. However, clinicians do not have a consistent means to evaluate PRP as a biologic drug and as a result interpreting clinical reports can be challenging. Additionally, clinicians often do not have the necessary information to fully evaluate PRP kits and protocols when deciding on how to best integrate this therapy into their practice. This paper defines 15 different metrics that can be used to quantify PRP and to compare PRP kits and protocols. Our goal is to provide a comprehensive framework that allows for the unbiased evaluation of PRP regardless of the kit or protocol used. By using these PRP metrics routinely, we can improve characterization PRP for research and clinical purposes.
"根据我的经验......15 个数据点可更好地评估富血小板血浆试剂盒和方案"
富血小板血浆(PRP)在骨科领域的应用日益广泛。临床研究记录了对各种病症的有效治疗结果,这激发了人们对富血小板血浆的兴趣,因为它可以安全地干预骨科中的许多软组织和关节病症。然而,临床医生并没有一致的方法将 PRP 作为生物药物进行评估,因此解释临床报告可能具有挑战性。此外,临床医生在决定如何将这种疗法最好地融入其临床实践时,往往没有必要的信息来全面评估 PRP 套件和方案。本文定义了 15 种不同的指标,可用于量化 PRP 以及比较 PRP 套件和方案。我们的目标是提供一个全面的框架,无论使用何种试剂盒或方案,都能对 PRP 进行公正的评估。通过常规使用这些 PRP 指标,我们可以改进用于研究和临床目的的 PRP 特征描述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信